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3Hypoglycemia and feeding difficulties are common 
among infants admitted to neonatal units because 
of impaired adaptation. In rare cases, however, these 
are the first signs of an underlying chronic disease. 
The first case describes a newborn infant that was re-
ferred to our tertiary care center because of hypogly-
cemia and respiratory distress syndrome. Apart from 
hypoglycemia, the baby displayed feeding difficulties, 
which could not be fully explained by the respiratory 
distress. Therefore, a cerebral ultrasound was perfor-
med which led to the final diagnosis of a rare disease. 
The same disease was diagnosed in a late preterm in-
fant, in whom the cerebral ultrasound was performed 
as a routine examination. We would like to present the 
different manifestations of a rare underlying disease 
that was diagnosed in both cases.
The first patient was born to healthy, non-consangui-
neous parents at 37 1/7 week of gestation. Except for 
maternal pyelonephritis during the 32nd week of ge-
station, the pregnancy had been uneventful. A Cae-
sarean section was performed 46 hours after rupture 
of membranes due to failure to progress. Apgar scores 
were was 7, 8, and 9 at 1, 5, and 10 minutes, re-
spectively; umbilical arterial cord- pH was 7.28. Birth 
weight was 2750g (P10-25), length 47 cm (P3-10) 
and head circumference 34 cm (P25-50). Respiratory 
distress became apparent in the first minutes of life 
with tachypnea (respiratory rate of 90/min), interco-
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4stal retractions and intermittent nasal flaring. Supple-
mental oxygen was provided during the first minutes 
of life. At the age of 5 hours, the baby seemed to be 
somnolent. Hypothermia of 35.7 °C and hypoglycemia 
of 0.5 mmol/l were noted. After oral administration 
of Maltodextrose, the blood glucose level only rose to 
1.5 mmol/l, and the patient was referred to our tertia-
ry care center for further management. 
On admission at the age of 8 hours, the patient presen-
ted with respiratory distress and an oxygen require-
ment (FiO2 0.25). No dysmorphic signs were noted. 
In addition to enteral feedings (by nasogastric tube 
due to poor feeding), an infusion of glucose 10% was 
provided, and blood glucose levels normalized. On the 
4th day of life, parenteral administration of glucose 
was discontinued. Although respiratory distress had 
completely resolved by the 3rd day of life, feeding dif-
ficulties persisted. A cerebral ultrasound performed on 
the 4th day of life revealed an absent septum pelluci-
dum (Fig. 1). 
MRI of the brain (Fig. 2, 3) confirmed this finding, and, 
in addition, revealed hypoplasia of the optic nerves, 
of the optic chiasm and the optical tract, hypopla-
sia of the genu and rostrum of the corpus callosum, 
as well as aplasia of the olfactory bulb. The pituitary 
gland was of low normal volume. Ophthalmological 
examination confirmed hypoplasia of the optic nerve, 
and no reaction to light could be observed. Other-
5wise, neurological examination was normal. These fin-
dings were consistent with a diagnosis of septo-optic 
dysplasia. The initial feeding difficulties resolved and, 
at the age of two weeks, the patient gained weight 
normally with bottle-feeding. 
The results of the neonatal screening tests were nor-
mal. Since hormonal problems are common in septo-
optic dysplasia, a detailed hormonal screening was 
performed and showed a TSH of 5.86 mU/l (normal 
range 0.43 - 16.1), fT4 16 pmol/l (normal range 22 - 
45), human growth hormone (HGH) 4.4 μg/l (normal 
range 0.69 - 17.3), cortisol 157 nmol/l (normal range 
171 - 537), ACTH 36 ng/l (normal range < 46). Becau-
se fT4 concentration was too low for age, our patient 
was treated with thyroxin 12.5 μg/day from the 8th 
day of life. 
On the 18th day of life, the patient could be dischar-
ged home. Neurological examination at the age of 2 
months still revealed absent fixation, but was other-
wise normal.
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Cerebral ultrasound (patient 1): coronal view at the 
level of foramina of Monro, showing absence of 
septum pellucidum.
Fig. 1
7MRI T2w TSE (turbo spin sequence, coronal view) 
(patient 1): absent septum pellucidum, hypoplasia of 
the optic chiasm (asterisk).
*
Fig. 2
8MRI T2w (3D FIESTA Sequence, axial view) (patient 1): 
hypoplasia of the optic nerves  (arrow heads). 
Fig. 3
9CASE rEpOrT 2The second patient was born to healthy, non-consan-
guineous parents at 34 0/7 weeks of gestation. An 
emergency Caesarean section was performed because 
of fetal bradycardia and suspected placental abruption. 
Apgar scores were 7, 8, and 8 at 1, 5, and 10 minutes, 
respectively, and the umbilical arterial cord-pH was 
7.19. Birth weight was 1950 g (P10-25), length 41.5 
cm (P3-10) and head circumference 31 cm (P10-25). 
Because of worsening respiratory distress, the patient 
was intubated and surfactant was administered on the 
first day of life. Extubation followed on the 4th post-
natal day, and the respiratory symptoms completely 
resolved by the 9th day of life. 
Routine cerebral ultrasound performed on the 1st 
postnatal day was remarkable for an absent septum 
pellucidum (Fig. 4). MRI confirmed the absence of the 
septum pellucidum and demonstrated hypoplasia of 
the optical nerves, thus establishing the diagnosis of 
septo-optic dysplasia (Fig. 5, 6). Ophthalmological ex-
amination showed severe hypoplasia of the optic ner-
ves, likely to cause severe visual impairment.
The boy developed hypernatremia on the 3rd postnatal 
day (max. 156 mmol/l), which was initially corrected 
through increase of fluid supply. Despite increasing 
fluid intake, hypernatremia and polyuria persisted and 
were interpreted as a central diabetes insipidus. The-
rapy with desmopressin was started and the sodium 
levels normalized. ACTH and cortisol levels were in the 
10
normal range. Because fT4 level was low (12.4 pmol/l) 
and TSH was normal (1.7mU/l), tertiary hypothyreosis 
was diagnosed and thyroxin supplementation was 
started. 
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Fig. 4
Cerebral ultrasound (patient 2): coronal view at the 
level of foramina of Monro, showing absence of 
septum pellucidum.
12
MRI T2w TSE (turbo spin sequence, axial view) 
(Patient 2): hypoplasia of the optic nerves (arrows).
Fig. 5
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MRI T1w 3D (gradient echo sequence, sagittal view) 
(patient 2): adenohypophysis (arrow), 
neurohypophysis (arrow head), infundibulum 
(asterisk).
Fig. 6
*
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DISCuSSION Septo-optic dysplasia (SOD) is a condition characte-
rized by the presence of at least two findings of the 
classical triad that consists of optic nerve hypoplasia or 
aplasia, pituitary hormone abnormalities and midline 
brain defects (1). The incidence of SOD is 1:10’000 live 
births, equally prevalent in males and females (2), and 
more common in infants born to younger mothers (3). 
Severity of the clinical manifestations is highly varia-
ble. The most commonly reported clinical findings are 
hypopituitarism (62-80%, mostly human growth hor-
mone deficiency), visual impairment (23%, with signi-
ficant visual impairment) and developmental delay (3). 
Developmental delay is more common in children with 
bilateral (57%) as compared to unilateral (32%) hypo-
plasia of the optic nerve (3). Early diagnosis is impor-
tant in order to avoid complications, such as hypo-
glycemia or hypothyroidism that may further impair 
neurological development. 
Although SOD is usually diagnosed beyond the neo-
natal period, these two cases show that the diagnosis 
can also be made in newborn infants. Clinically, SOD 
should be suspected in newborns with unexplained or 
persistent hypoglycemia, jaundice, nystagmus or mid-
line defects. Because early diagnosis may be associa-
ted with a better outcome, SOD must be considered in 
newborn infants who present with these clinical symp-
toms. 
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